Plan B's Problem With Heavier Women Isn't News in EuropeBy
When Teva Pharmaceuticals gained exclusive rights from the Food and Drug Administration to market Plan B One-Step as an over-the-counter emergency contraceptive for “all women of child-bearing potential” this year, advocates considered it a victory for reproductive rights. But a new labeling change for an identical drug in Europe now raises the prospect that the treatment may not work for women weighing more than 165 pounds.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.